Eden BioSolutions plc (EDNSF) Stock Price & Analysis
Eden BioSolutions plc (EDNSF) — price $0.0499 (0.00%), as of the Nov 19, 2026 trading session; market cap $40.1M.
Educational signal · not a buy or sell recommendation · How to read this
Eden BioSolutions plc · EDNSF
Eden Research plc develops and supplies sustainable solutions for crop protection, animal health, and human health across the UK and Europe. The company leverages its proprietary technology to offer environmentally conscious alternatives in agricultural inputs and consumer products.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0499 | |
| Change on the day | 0.00% | |
| Market capitalisation | $40.1M | |
| Shares traded on the day | 10.0K |
Price & events
Other perspectives
Council score for Eden BioSolutions (EDNSF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Eden BioSolutions (EDNSF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Eden BioSolutions plc (EDNSF) is the company analyzed here. It employs 23 people. In Q2 FY2025 it reported revenue of £1M and net income of -£2M. The market values it at $40.1M.
What do the latest results show for Eden BioSolutions (EDNSF)?
Short answer · as of
The most recent reported quarter, Q2 FY2025, carried revenue of £1M.
Quarterly income statement — 3 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2025 | £1M | -£2M | -£0.0025 (diluted) |
| Q4 FY2024 | £2M | -£990,463 | -£0.0019 (diluted) |
| Q2 FY2024 | £2M | -£916,128 | -£0.0017 (diluted) |
What are the financial strengths and risks for Eden BioSolutions (EDNSF)?
Short answer · as of
The distress and quality screens read Altman Z 5.93 · Piotroski F 1. Trailing ratios: ROE -16.2% · ROA -12.0% · current ratio 1.95 · earnings yield -11.1% · free-cash-flow yield -9.3%.
Data-derived red flags
- Negative return on equity (-16.2%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
What should you watch next at Eden BioSolutions (EDNSF)?
Short answer · as of
Analyst estimates on file carry FY2027 revenue $6.11M · EPS -0.00 · 1 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
- The newest quarter held here (Q2 FY2025) was filed Jun 30, 2025 — 11 months ago.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $6.11M
- EPS estimate
- $-0.00
Measured against a quoted price of $0.0499 (as of Nov 19, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held EDNSF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported EDNSF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Eden BioSolutions (EDNSF)?
Common Questions About EDNSF
These answers are editorial: 1 of these 8 answers is drawn from the EDNSF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is EDNSF a good stock to buy?
Stock Expert AI does not rate EDNSF buy, sell or hold. Eden BioSolutions plc has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the EDNSF stock price today?
The last price recorded for Eden BioSolutions plc (EDNSF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Eden Research plc do?
Eden Research plc specializes in developing and supplying sustainable, natural solutions across three primary segments: crop protection, animal health, and human health.
What are the key factors to evaluate for EDNSF?
Evaluate EDNSF on fundamentals, analyst consensus, and risk factors. Diversification into New Application Areas: Eden Research's core technology, based on natural active ingredients, has demonstrated versatility across crop protection, animal health, and human health. Not financial advice.
How frequently does EDNSF data refresh on this page?
EDNSF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven EDNSF's recent stock price performance?
Eden BioSolutions plc (EDNSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialization in sustainable, natural solutions for diverse markets. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EDNSF overvalued or undervalued right now?
Eden BioSolutions plc (EDNSF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research EDNSF before investing?
Before investing in Eden BioSolutions plc (EDNSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 9 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com